The RUBIC Seminar on 23 February marked an important milestone for the ReproUnion Biobank & Infertility Cohort. What began as an ambitious cross-border research infrastructure is now delivering concrete scientific results – based on biological samples and detailed health data from 2,000 couples undergoing fertility treatment.

As part of a dedicated working group, ReproUnion experts bring together clinical experience and research-based knowledge in a report focusing on involuntary childlessness.

The matchmaking and co-creation event brought together startups, clinicians, researchers, and industry with the aim of exploring how collaboration and testbed frameworks can help accelerate innovation in the field of reproductive medicine.

At the 2025 ASRM Scientific Congress in October, Aleksander Giwercman delivered a keynote, highlighting the health of the male partner as a crucial aspect of fertility and the need for a couple-centered approach.

In November ReproUnion joined leading voices in cross-border innovation at the 2025 Medicon Valley Alliance Annual Summit 2025 – a day where EU competitiveness met health innovation in practice.

Congratulations to Eva Elmerstig and her research team on the SEK 2 million grant from the Mats Paulsson Foundation to advance their work on eHealth support for involuntary childlessness.

ReproUnion celebrated the milestone with all contributing fertility and reproductive clinics who play a crucial role in collecting and processing the biological material and data that makes RUBIC possible.

By blending expert lectures with practical exercises, the course equipped the participants with insights and tools, which they can put directly into practice, if they wish to pursue the journey from science to commercialisation.

The third ReproTalk event on 8 September tuned in on how researchers and clinicians at Rigshospitalet are helping to set the global standard for fertility preservation ahead of treatments that may harm the reproductive potential for both girls and women.

It builds on research published in Human Reproduction showing that paracetamol may impair the development of the fertilized egg in the very first days after conception.